Acrolein decreases paraoxonase 1 (PON-1) activity in HDL: protection by cysteine.

被引：0
|
作者：
Lunceford, N. [1 ]
Tran, L. [1 ]
Rose, M. [1 ]
Schulze, J. [1 ]
Gusliucci, A. [1 ]
机构：
[1] Touro Univ, Vallejo, CA USA
来源：
CLINICAL CHEMISTRY | 2007年 / 53卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
A137
引用
收藏
页码：A43 / A43
页数：1
相关论文
共 50 条
  • [21] Paraoxonase and arylesterase activity of serum PON-1 enzyme in psoriatic patients: a systematic review and meta-analysis
    Bassu, Stefania
    Mangoni, Arduino A.
    Satta, Rosanna
    Argiolas, Dario
    Carru, Ciriaco
    Zinellu, Angelo
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (02) : 301 - 311
  • [22] Paraoxonase and arylesterase activity of serum PON-1 enzyme in psoriatic patients: a systematic review and meta-analysis
    Stefania Bassu
    Arduino A. Mangoni
    Rosanna Satta
    Dario Argiolas
    Ciriaco Carru
    Angelo Zinellu
    Clinical and Experimental Medicine, 2023, 23 : 301 - 311
  • [23] Modulation of paraoxonase (PON1) activity
    Costa, LG
    Vitalone, A
    Cole, TB
    Furlong, CE
    BIOCHEMICAL PHARMACOLOGY, 2005, 69 (04) : 541 - 550
  • [24] Injection of paraoxonase 1 (PON1) to mice stimulates their HDL and macrophage antiatherogenicity
    Rosenblat, Mira
    Volkova, Nina
    Aviram, Michael
    BIOFACTORS, 2011, 37 (06) : 462 - 467
  • [25] Cellular localization, HDL subfraction distribution and antioxidant role of paraoxonase 1 (PON 1)
    Trudel, K
    James, RW
    Sinnett, D
    Delvin, E
    Garofalo, C
    Seidman, E
    Levy, É
    FASEB JOURNAL, 2005, 19 (05): : A980 - A981
  • [26] VLDL triglycerides inhibit HDL-associated paraoxonase 1 (PON1) activity: in vitro and in vivo studies
    Rosenblat, Mira
    Ward, Sarah
    Volkova, Nina
    Hayek, Tony
    Aviram, Michael
    BIOFACTORS, 2012, 38 (04) : 292 - 299
  • [27] Involvement of homocysteine, homocysteine thiolactone, and paraoxonase type 1 (PON-1) in the etiology of defective human sperm function
    Aitken, R. J.
    Flanagan, H. M.
    Connaughton, H.
    Whiting, S.
    Hedges, A.
    Baker, M. A.
    ANDROLOGY, 2016, 4 (02) : 345 - 360
  • [28] Pharmacological Interactions of Paraoxonase 1 (PON1): A HDL-Bound Antiatherogenic Enzyme
    Mahrooz, Abdolkarim
    CURRENT CLINICAL PHARMACOLOGY, 2016, 11 (04): : 259 - 264
  • [29] GENETIC POLYMORPHISM IN PARAOXONASE 1 (PON1): POPULATION DISTRIBUTION OF PON1 ACTIVITY
    Ginsberg, Gary
    Neafsey, Patricia
    Hattis, Dale
    Guyton, Kathryn Z.
    Johns, Douglas O.
    Sonawane, Babasaheb
    JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS, 2009, 12 (5-6): : 473 - 507
  • [30] Exploring the Relationship between Canine Paraoxonase-1 (PON-1) Serum Activity and Liver Disease Classified by Clinico-Pathological Evaluation
    Meazzi, Sara
    Bristi, Sabiha Zarin Tasnim
    Bianchini, Virginia
    Scarpa, Paola
    Giordano, Alessia
    ANIMALS, 2024, 14 (19):
12345